NCT02744417

Brief Summary

The aim of this prospective interventional study is to verify the efficacy of smoking cessation on clinical and microbiological outcomes of non-surgical periodontal therapy of chronic periodontitis patients. Smokers willing to quit received periodontal treatment and concurrent smoking cessation therapy. Periodontal maintenance was performed every 3 months. A single calibrated examiner, blinded to smoking status, assessed periodontal clinical outcomes and applied a structured questionnaire in order to collect demographic and behavioural information. Further, expired carbon monoxide concentration were measured with a monoximeter. A pooled subgingival plaque sample was collected from the deepest periodontal pocket from each participant. The presence and quantification of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola were determined using (RT-PCR).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2010

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

April 13, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2016

Completed
Last Updated

November 6, 2018

Status Verified

November 1, 2018

Enrollment Period

3.5 years

First QC Date

April 13, 2016

Last Update Submit

November 3, 2018

Conditions

Keywords

smoking cessationtobaccoperiodontalsubgingival microorganisms

Outcome Measures

Primary Outcomes (1)

  • Change in Clinical Attachment Level

    Change in Clinical Attachment Level (millimeters) after 12 months

    baseline - 12 months

Secondary Outcomes (8)

  • Change in Gingival recession

    baseline - 12 months

  • Change in Pocket depth

    baseline - 12 months

  • Change in bleeding on probing

    baseline - 12 months

  • Change in visible plaque

    baseline - 12 months

  • Prevalence and levels of Aggregatibacter actinomycetemcomitans

    baseline - 12 months

  • +3 more secondary outcomes

Study Arms (1)

Smoking cessation therapy

EXPERIMENTAL

Non-surgical periodontal therapy and concurrent smoking cessation therapy, with Smoking cessation counseling, Nicotine replacement therapy, use of bupropion hydrochloride and varenicline

Behavioral: Smoking cessation counselingProcedure: Non-surgical periodontal therapyDrug: Nicotine replacement therapyDrug: bupropion hydrochlorideDrug: Varenicline

Interventions

Multidisciplinary smoking cessation counseling, performed by a team comprising physicians, nurses, a psychologist and dentists. It consisted of four 1-h counselling lectures delivered by physicians, psychologist-assisted cognitive behavioural therapy, and counseling provided by dentists during the active phase of the treatment and maintenance session, using motivational interviewing techniques

Smoking cessation therapy

Full-mouth supra and subgingival scaling and root planing (with curettes and ultrasonic scaler); oral hygiene instruction and motivation and removal of intra-oral plaque retentive factors

Smoking cessation therapy

Nicotine replacement therapy: chewing gum (Nicorette chewing gum 2-4mg) and patches (Nicorette patches 15-25mg)

Also known as: Nicorette
Smoking cessation therapy

bupropion hydrochloride 150mg

Also known as: Zyban
Smoking cessation therapy

Varenicline 0,5mg

Also known as: Champix
Smoking cessation therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • smokers willing to stop smoking
  • \>10 teeth
  • periodontitis (30% or more of their teeth with proximal attachment loss ≥ 5 mm)

You may not qualify if:

  • systemic conditions considered as risk factors for periodontal disease,
  • periodontal therapy in the last 6 months
  • continuous systemic use of anti-inflammatory or steroidal drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Guglielmetti MR, Rosa EF, Lourencao DS, Inoue G, Gomes EF, De Micheli G, Mendes FM, Hirata RD, Hirata MH, Pannuti CM. Detection and quantification of periodontal pathogens in smokers and never-smokers with chronic periodontitis by real-time polymerase chain reaction. J Periodontol. 2014 Oct;85(10):1450-7. doi: 10.1902/jop.2014.140048. Epub 2014 May 2.

MeSH Terms

Conditions

PeriodontitisSmoking Cessation

Interventions

Nicotine Replacement TherapyNicotine Chewing GumBupropionVarenicline

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeuticsChewing GumPlant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesTobacco Use Cessation DevicesCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesPropiophenonesKetonesOrganic ChemicalsBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsQuinoxalines

Study Officials

  • Claudio M Pannuti, PhD

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The outcome assessor was blind to smoking status. Before each follow-up periodontal examination (3, 6 and 12 months), the following procedures were performed by a periodontist: (1) removal of all tobacco stains from subject's teeth and/or dental polishing, with a standardized duration of up to 30 min., (2) 0.12% chlorohexidine rinse (1min.) aimed to hide any possible cigarette odour exhaled from the oral cavity. After these procedures, the examiner entered the examination room fully equipped (including a mask), in order to avoid noticing the smoking status by odour
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 13, 2016

First Posted

April 20, 2016

Study Start

August 1, 2010

Primary Completion

February 1, 2014

Study Completion

March 1, 2014

Last Updated

November 6, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share